v3.22.1
Loss Per Share (Details) - Schedule of common share equivalent basis and outstanding - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total diluted shares 214,946,110 155,187,200
Convertible notes payable [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total diluted shares 214,946,110 155,187,200